Loading...
XNAS
CELZ
Market cap10mUSD
Jul 09, Last price  
3.94USD
1D
46.47%
1Q
118.89%
IPO
34,160.87%
Name

Creative Medical Technology Holdings Inc

Chart & Performance

D1W1MN
No data to show
P/E
P/S
926.09
EPS
Div Yield, %
Shrs. gr., 5y
310.81%
Rev. gr., 5y
-41.85%
Revenues
11k
+22.22%
000000000004,800124,400165,500164,50087,75488,6009,00011,000
Net income
-5m
L+3.91%
1,372-9,544-52,636-31,610-17,256-24,055-25,585-27,282-28,012-30,761-766,072-2,659,108-13,655,653-10,379,201-37,554,82014,933,335-10,043,716-5,286,574-5,493,481
CFO
-5m
L-33.96%
1,139-12,857-57,164-30,742-13,661-13,959-16,774-22,907-17,320-14,638-445,232-889,621-1,052,270-1,213,093-434,556-2,215,782-7,796,966-8,027,884-5,301,292
Earnings
Aug 07, 2025

Profile

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
IPO date
May 01, 2009
Employees
4
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
11
22.22%
9
-89.84%
89
0.96%
Cost of revenue
2,405
1,974
6,297
Unusual Expense (Income)
NOPBT
(2,394)
(1,965)
(6,209)
NOPBT Margin
Operating Taxes
(100)
Tax Rate
NOPAT
(2,394)
(1,965)
(6,108)
Net income
(5,493)
3.91%
(5,287)
-47.36%
(10,044)
-167.26%
Dividends
Dividend yield
Proceeds from repurchase of equity
1,455
(271)
15,472
BB yield
-42.53%
4.18%
-3,713.64%
Debt
Debt current
14
Long-term debt
Deferred revenue
Other long-term liabilities
3,268
Net debt
(5,940)
(9,987)
(18,385)
Cash flow
Cash from operating activities
(5,301)
(8,028)
(7,797)
CAPEX
Cash from investing activities
6,320
3,445
(10,079)
Cash from financing activities
1,455
(271)
15,472
FCF
(2,394)
(1,965)
(6,108)
Balance
Cash
5,940
9,987
18,399
Long term investments
Excess cash
5,940
9,987
18,395
Stockholders' equity
(64,590)
(59,097)
(53,798)
Invested Capital
70,932
69,441
69,677
ROIC
ROCE
EV
Common stock shares outstanding
1,480
1,408
1,093
Price
2.31
-49.89%
4.61
1,109.66%
0.38
-82.76%
Market cap
3,420
-47.30%
6,489
1,457.58%
417
-41.97%
EV
(2,521)
(3,498)
(17,968)
EBITDA
(2,284)
(1,871)
(6,117)
EV/EBITDA
1.10
1.87
2.94
Interest
100
Interest/NOPBT